menu
Research
Today's research for tomorrow's cure
Our Science
Research Groups
Facilities & Platforms
Clinical research
Find a researcher
Publications
Knowledge Transfer
Support us
Careers & study
Become a leader in cancer research
Vacancies
Faculty
Scientific staff
Scientific support staff
Postdoctoral fellows
Students
Operational staff
Clinical fellows
Life in Amsterdam
Support us
News & Events
Check out our stories and backgrounds
News
Thematic collections
Media & Press
Calendar
Support us
About us
Maximum impact for cancer patients
Our vision
Organization
Collaborations
Responsible Research
Support us
Visit us
Contact us
Support us
Support us
Search
Support us
RESEARCH
PUBLICATIONS
RE: NEOADJUVANT PD-L1 PLUS CTLA-4 BLOCKADE IN PATIENTS WITH CISPLATIN-INELIGIBLE OPERABLE HIGH-RISK UROTHELIAL CARCINOMA.
Re: Neoadjuvant PD-L1 plus CTLA-4 Blockade in Patients with Cisplatin-ineligible Operable High-risk Urothelial Carcinoma.
Show more authors
+ 1
Sarah M H Einerhand
Jeroen van Dorp
Michiel S van der Heijden
Bas W G van Rhijn
More about this publication
European urology
Volume 83
Issue nr. 1
Pages 91-92
Publication date 01-01-2023
Full text links
Publisher website (DOI)
10.1016/j.eururo.2022.09.024
Europe PubMed Central
36210214
Pubmed
36210214
Disclaimer
Privacy statement
Cookies
This site uses cookies
This website uses cookies to ensure you get the best experience on our website.